BCL7A and diffuse large B-cell lymphoma: Over 50%, and up to 70%, of mutations in BCL7A in DLBCL are either truncating or within three mutational hotspots: the start codon, arginine 11, or the first splice donor site (Fig. 2B) [9, 86].